about
BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapyRetro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients.CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does notOverexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast CancerInhibition of stromal CXCR4 impairs development of lung metastases.Increased HOX C13 expression in metastatic melanoma progression.Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types.Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant MelanomaHyperexpression of HOXC13, located in the 12q13 chromosomal region, in well‑differentiated and dedifferentiated human liposarcomas.Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancersDifferential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival.PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.Microenvironment and tumor progression of melanoma: new therapeutic prospectives.CD90 expression in atypical meningiomas and meningioma metastasis.Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo.Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression.HOTAIR role in melanoma progression and its identification in the blood of patients with advanced disease.Duodenal gangliocytic paraganglioma, a rare entity among GEP-NET: a case report with immunohistochemical and molecular study.Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival.TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung.PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays.Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients.Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma.Immune Checkpoint Inhibitors in Melanoma and HIV Infection.Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP.New cell block containing agarose for cytopathological diagnosis of tumor samples.LncRNA HOTAIR polymorphisms association with cancer susceptibility in different tumor types.Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.Characterization of respiratory infection viruses in hospitalized children from Naples province in Southern Italy.CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous bloodRANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells.
P50
Q28564542-31174EE6-15AD-45A2-B0EF-7AA331003C42Q33683537-9F42EC95-FB49-4DC2-BC46-1EC605603812Q35781562-F8DFFEA2-F46A-4925-A331-83E88FE0E2C0Q35833601-D94048A3-5B60-497A-91B8-735B2983C88EQ36092011-1CFE6C43-2F3B-472D-B8D6-878B09CF251BQ36250217-ADBC1597-21FA-4619-B676-E5C71983E5B7Q36338556-4745245F-38A0-4DF7-972D-3C06B1029A27Q36939402-13435645-07B2-4309-AC0A-63812206E47EQ37102302-E503C9EB-A29A-474F-9CD8-2DB75F2A874DQ37341266-584647C0-83C7-4B52-8A36-602BDD827F0BQ37375359-8AF6B05F-3F60-432C-BAF8-E790594561F9Q37636757-186E605F-E207-4A83-BB98-F8B7038B4021Q37644833-FC7268F9-9FEC-451E-953A-4D70179A6A69Q37663388-53E62FA5-14CA-41A3-A837-674BFA4FE36FQ37687273-65A8F9DB-6F8D-4A11-A60A-D7B18EE25FC0Q37688084-8C8FCDB1-6CCD-41A7-BE8B-7A6A2CC1DFA8Q37691082-D6FC83D0-1F62-4B4D-A571-CAAC8DEAB52EQ38049368-26C3FFFA-C5A8-4425-A558-BDCAD86F4018Q38212579-C2821CD8-F74C-497D-9FAF-F9BC4FC27740Q38628722-00425C86-33DA-49B0-A28C-FB5D8673D5B1Q38629943-5106E41F-271F-4919-8F2C-8B4D64001310Q38865724-9F935C9D-5FB5-40A3-887F-A57E010CF1FDQ38957953-24FB71C8-1D49-46E7-9F31-907005AA9C76Q39032235-AE46BC62-A0E7-4C2B-A040-ECDE06CBE1ABQ39170217-F5196B37-7BA8-4B93-BB44-CC4EB7B77E60Q39286125-17986249-B1D4-4E82-99BB-DAC791C9E521Q42090640-570C16FF-1E29-4D24-B260-BAE23BC42AE0Q42397391-146EFD60-E240-4D2C-85BE-3092F13BC09BQ43405791-3F2D6EBC-08BE-45DC-95BE-5EE9A6621428Q46228932-73C1E5FC-A09B-4357-AC65-FBA372448115Q47099687-E2CEAFAD-FBB4-4F09-91A5-67C60881CCBDQ47138765-A8DEE710-F0B7-426A-9204-157D50383D7CQ47774329-1F80258A-6202-4391-8452-0C5D87A098A0Q48192402-D216D415-8BF1-4870-8FA6-76FD4ED56B2FQ48197223-72BBD1E0-EF1D-4322-A333-FBFC6DB4A80DQ50578182-1B291114-81D7-49C4-ACD9-60E991F11852Q52860239-B7193423-A318-4E61-B127-EDA06D28F2C0Q55002075-8F69BB04-0B7B-454B-8741-CEB1D9F56828Q55013321-6ECAF61A-4B95-434E-BE97-40C3542FF7F6Q55153118-F9C73B26-8330-42A7-828E-E7966348155B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giosuè Scognamiglio
@ast
Giosuè Scognamiglio
@en
Giosuè Scognamiglio
@es
Giosuè Scognamiglio
@nl
Giosuè Scognamiglio
@sl
type
label
Giosuè Scognamiglio
@ast
Giosuè Scognamiglio
@en
Giosuè Scognamiglio
@es
Giosuè Scognamiglio
@nl
Giosuè Scognamiglio
@sl
prefLabel
Giosuè Scognamiglio
@ast
Giosuè Scognamiglio
@en
Giosuè Scognamiglio
@es
Giosuè Scognamiglio
@nl
Giosuè Scognamiglio
@sl
P1053
K-8247-2016
P106
P1153
36497386700
P21
P31
P3829
P496
0000-0003-4376-111X
P569
2000-01-01T00:00:00Z